KIMBERLY DUFRAUX: Open Payments
NPI 1770723058 · WESTMINSTER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,293 in 75 payments from 20 companies in 2025. Trend: 2023 $120 · 2024 $1,050 · 2025 $2,293
Food & beverage: $2,208Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $439 |
| Sumitomo Pharma America, Inc. | 17 | $391 |
| Teleflex LLC | 3 | $246 |
| Antares Pharma, Inc. | 11 | $192 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $148 |
| UROGEN PHARMA, INC. | 2 | $148 |
| PFIZER INC. | 6 | $131 |
| Astellas Pharma US Inc | 2 | $112 |
| Novartis Pharmaceuticals Corporation | 4 | $107 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $77 |
Products named: BARRIGEL, RYBREVANT, XTANDI, ORGOVYX, ERLEADA, XYOSTED, GEMTESA, Nubeqa.
Industry payments across CO — which companies pay providers there.
